Cases & Deals

Share

Xerys invests in Biolog-id

April 2015

Client(s) Xerys SA

Jones Day represented Xerys SA in connection with its purchase of Preferred Stock in a private placement by Biolog-id, a company focused on traceability solutions for health products and processes used for labile blood components.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.